Studies of recombinant interleukin-2 (RIL-2) administered by continuous intravenous infusion revealed hepatocellular toxicity and redistribution of lymphoid cells. This finding was different from the normal findings seen in rats receiving comparable infusions of the vehicle.
|Original language||English (US)|
|Number of pages||5|
|Journal||Journal of the National Medical Association|
|State||Published - Dec 1 1987|
ASJC Scopus subject areas